Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

The blood glucose-lowering effect of racecadotril is not attributable to inhibition of insulin-degrading enzyme.

Kurklinsky S, Abdul-Hay SO, McGuire MP, Howard EA, Knight J, Leissring MA.

Horm Metab Res. 2014 Jan;46(1):73-4. doi: 10.1055/s-0033-1353211. Epub 2013 Aug 23. No abstract available.

PMID:
23975847
2.

Inhibition of insulin degrading enzyme by racecadotril in the brain of Wistar rats.

Lee JP, Cheng KC, Chung HH, Wu HT, Chen CT, Cheng JT.

Horm Metab Res. 2011 Jun;43(7):489-93. doi: 10.1055/s-0031-1277183. Epub 2011 May 9.

PMID:
21557151
3.

Increase of plasma insulin by racecadotril, an inhibitor of enkephalinase, in Wistar rats.

Wu HT, Chang CK, Cheng KC, Chang CH, Yeh CH, Cheng JT.

Horm Metab Res. 2010 Apr;42(4):261-7. doi: 10.1055/s-0029-1246190. Epub 2010 Feb 8.

PMID:
20143290
4.
5.

Racecadotril: a new approach to the treatment of diarrhoea.

Schwartz JC.

Int J Antimicrob Agents. 2000 Feb;14(1):75-9. Review.

PMID:
10717505
6.

Effects of racecadotril and loperamide on bacterial proliferation and on the central nervous system of the newborn gnotobiotic piglet.

Duval-Iflah Y, Berard H, Baumer P, Guillaume P, Raibaud P, Joulin Y, Lecomte JM.

Aliment Pharmacol Ther. 1999 Dec;13 Suppl 6:9-14.

7.

An overview of clinical studies with racecadotril in adults.

Lecomte JM.

Int J Antimicrob Agents. 2000 Feb;14(1):81-7. Review.

PMID:
10717506
8.

Racecadotril.

Matheson AJ, Noble S.

Drugs. 2000 Apr;59(4):829-35; discussion 836-7. Review.

PMID:
10804038
9.

ATP inhibits insulin-degrading enzyme activity.

Camberos MC, PĂ©rez AA, Udrisar DP, Wanderley MI, Cresto JC.

Exp Biol Med (Maywood). 2001 Apr;226(4):334-41.

PMID:
11368426
10.

Rat brain insulin degrading enzyme in insulin and thyroid hormones imbalances.

Azam M, Gupta BL, Gupta G, Jain S, Baquer NZ.

Biochem Int. 1990;21(2):321-9.

PMID:
2206136
11.

Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.

Cordes CM, Bennett RG, Siford GL, Hamel FG.

Biochem Pharmacol. 2009 Mar 15;77(6):1064-73. doi: 10.1016/j.bcp.2008.12.006. Epub 2008 Dec 27.

PMID:
19154729
12.

Racecadotril demonstrates intestinal antisecretory activity in vivo.

Primi MP, Bueno L, Baumer P, Berard H, Lecomte JM.

Aliment Pharmacol Ther. 1999 Dec;13 Suppl 6:3-7.

13.
14.

Potentiation of the hypoglycemic effect of insulin by thiorphan, an enkephalinase inhibitor.

Chipkin RE, Kreutner W, Billard W.

Eur J Pharmacol. 1984 Jun 15;102(1):151-4.

PMID:
6383841
15.

Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes.

Gallelli L, Colosimo M, Tolotta GA, Falcone D, Luberto L, Curto LS, Rende P, Mazzei F, Marigliano NM, De Sarro G, Cucchiara S.

Eur J Clin Pharmacol. 2010 Feb;66(2):137-44. doi: 10.1007/s00228-009-0751-3. Epub 2009 Nov 10.

PMID:
19902197
16.

Comparison of racecadotril and loperamide in children with acute diarrhoea.

Turck D, Berard H, Fretault N, Lecomte JM.

Aliment Pharmacol Ther. 1999 Dec;13 Suppl 6:27-32.

17.

Racecadotril versus placebo in the treatment of acute diarrhoea in adults.

Hamza H, Ben Khalifa H, Baumer P, Berard H, Lecomte JM.

Aliment Pharmacol Ther. 1999 Dec;13 Suppl 6:15-9.

18.

Spectrophotometric and spectrofluorimetric methods for determination of Racecadotril.

Ali NW, Elghobashy MR, Mahmoud MG, Mohammed MA.

Pak J Pharm Sci. 2011 Jan;24(1):19-23.

PMID:
21190913
20.

A multinational comparison of racecadotril and loperamide in the treatment of acute watery diarrhoea in adults.

Prado D; Global Adult Racecadotril Study Group..

Scand J Gastroenterol. 2002 Jun;37(6):656-61.

PMID:
12126242

Supplemental Content

Support Center